ANKRD22 and nasopharyngeal carcinoma: Our results showed that METTL14 and ANKRD22 expression levels were upregulated in NPC tissues, and high expression of METTL14 and ANKRD22 was linked to a worse prognosis for the patients as indicated by survival analysis.